VERO · Venus Concept Inc. - Financials
Annual line items from SEC XBRL filings, sourced from EDGAR's Company Facts API with fallback to the quarterly Financial Statement Data Sets. See issuer overview for Form 4 activity and 10-K signals.
Income Statement
| Line item | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $13.78M | $15.69M | $13.64M | - | $15.01M | $16.58M | $17.48M | - | $17.62M | $20.07M |
| Cost of Revenue | $4.96M | $6.26M | $4.89M | - | $5.09M | $4.73M | $5.83M | - | $5.43M | $5.86M |
| Gross Profit | $8.82M | $9.43M | $8.76M | - | $9.92M | $11.85M | $11.65M | - | $12.19M | $14.22M |
| R&D | $1.28M | $1.35M | $1.56M | - | $1.69M | $1.74M | $1.78M | - | $1.93M | $1.97M |
| SG&A | $9.65M | $9.43M | $9.73M | - | $8.73M | $8.66M | $10.25M | - | $10.12M | $9.63M |
| Total Operating Expenses | $18.31M | $18.47M | $18.28M | - | $17.08M | $17.45M | $19.41M | - | $18.95M | $19.98M |
| D&A | $101.0K | $89.0K | $950.0K | - | $98.0K | $113.0K | $975.0K | - | $134.0K | $144.0K |
| Operating Income | ($9.50M) | ($9.04M) | ($9.53M) | - | ($7.16M) | ($5.60M) | ($7.76M) | - | ($6.76M) | ($5.76M) |
| Interest Expense | $1.15M | $1.11M | $1.32M | - | $1.49M | $1.83M | $2.08M | - | $1.54M | $1.49M |
| Income Tax | $531.0K | $214.0K | $338.0K | - | ($31.0K) | $141.0K | $37.0K | - | ($321.0K) | $189.0K |
| Net Income | ($22.57M) | ($11.72M) | ($12.36M) | - | ($9.29M) | ($19.95M) | ($9.79M) | - | ($14.61M) | ($7.41M) |
| EPS - Basic | ($12.14) | ($8.03) | ($17.44) | - | ($14.08) | ($33.55) | ($18.48) | - | ($18.04) | ($14.85) |
| EPS - Diluted | ($12.14) | ($8.03) | ($17.44) | - | ($14.08) | ($33.55) | ($18.48) | - | ($18.04) | ($14.85) |
Balance Sheet
| Line item | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $4.31M | $3.88M | $3.20M | $4.27M | $4.49M | $5.73M | $5.09M | $5.40M | $4.93M | $6.12M |
| Accounts Receivable | $16.50M | $15.77M | $16.78M | $18.72M | $21.10M | $24.58M | $27.17M | $29.15M | $34.18M | $37.52M |
| Inventory | $15.77M | $15.86M | $17.63M | $17.56M | $18.90M | $19.78M | $20.98M | $23.07M | $23.39M | $22.94M |
| Accounts Payable | $7.11M | $5.85M | $7.37M | $6.48M | $7.12M | $7.19M | $7.79M | $9.04M | $7.12M | $8.29M |
| Current Assets | $45.82M | $45.11M | $45.60M | $48.51M | $51.22M | $56.90M | $60.70M | $66.45M | $71.77M | $75.79M |
| Total Assets | $61.62M | $63.09M | $63.46M | $68.18M | $72.28M | $79.75M | $85.08M | $93.65M | $98.92M | $106.16M |
| Current Liabilities | $50.65M | $41.12M | $35.61M | $30.29M | $27.47M | $28.54M | $29.45M | $31.16M | $26.00M | $34.94M |
| Long-term Debt | $5.00M | $15.87M | $21.57M | $31.44M | $30.02M | $42.40M | $72.55M | $70.79M | $79.05M | $70.68M |
| Total Liabilities | $58.49M | $60.31M | $60.73M | $65.35M | $61.65M | $75.39M | $106.99M | $107.10M | $110.30M | $111.70M |
| Stockholders' Equity | $2.67M | $2.33M | $2.26M | $2.37M | $10.11M | $3.70M | ($22.49M) | ($14.02M) | ($12.17M) | ($6.22M) |
| Retained Earnings | ($355.55M) | ($332.98M) | ($321.26M) | ($308.90M) | ($300.93M) | ($291.65M) | ($271.70M) | ($261.90M) | ($250.79M) | ($241.72M) |
Cash Flow
| Line item | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | ($6.31M) | - | - | - | ($2.88M) | - | - | - |
| Investing Cash Flow | - | - | ($35.0K) | - | - | - | ($25.0K) | - | - | - |
| Financing Cash Flow | - | - | $5.27M | - | - | - | $2.59M | - | - | - |
| CapEx | - | - | $35.0K | - | - | - | $25.0K | - | - | - |
| Free Cash Flow | - | - | ($6.34M) | - | - | - | ($2.90M) | - | - | - |
Ratios
| Metric | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 |
|---|---|---|---|---|---|---|---|---|---|---|
| Profitability | ||||||||||
| Gross margin | 64.0% | 60.1% | 64.2% | - | 66.1% | 71.5% | 66.6% | - | 69.2% | 70.8% |
| Operating margin | -68.9% | -57.6% | -69.8% | - | -47.7% | -33.7% | -44.4% | - | -38.4% | -28.7% |
| EBITDA margin | -68.2% | -57.0% | -62.9% | - | -47.0% | -33.1% | -38.8% | - | -37.6% | -28.0% |
| Net margin | -163.8% | -74.7% | -90.6% | - | -61.9% | -120.3% | -56.0% | - | -82.9% | -36.9% |
| Free cash flow margin | - | - | -46.5% | - | - | - | -16.6% | - | - | - |
| FCF / Net income | - | - | 0.51 | - | - | - | 0.30 | - | - | - |
| R&D / Revenue | 9.3% | 8.6% | 11.4% | - | 11.3% | 10.5% | 10.2% | - | 10.9% | 9.8% |
| SG&A / Revenue | 70.0% | 60.1% | 71.4% | - | 58.2% | 52.2% | 58.6% | - | 57.4% | 48.0% |
| Effective tax rate | - | - | - | - | - | - | - | - | - | - |
| Return on assets | -36.6% | -18.6% | -19.5% | - | -12.8% | -25.0% | -11.5% | - | -14.8% | -7.0% |
| Return on equity | -844.2% | -503.7% | -546.6% | - | -91.9% | -538.9% | 43.6% | - | 120.0% | 119.1% |
| Return on invested capital | -97.8% | -39.3% | -31.6% | - | -14.1% | -9.6% | -12.2% | - | -8.0% | -7.1% |
| Liquidity | ||||||||||
| Current ratio | 0.90 | 1.10 | 1.28 | 1.60 | 1.86 | 1.99 | 2.06 | 2.13 | 2.76 | 2.17 |
| Quick ratio | 0.59 | 0.71 | 0.79 | 1.02 | 1.18 | 1.30 | 1.35 | 1.39 | 1.86 | 1.51 |
| Cash ratio | 0.09 | 0.09 | 0.09 | 0.14 | 0.16 | 0.20 | 0.17 | 0.17 | 0.19 | 0.18 |
| Leverage | ||||||||||
| Debt / Equity | 1.87 | 6.82 | 9.53 | 13.27 | 2.97 | 11.45 | -3.23 | -5.05 | -6.50 | -11.36 |
| Debt / Assets | 0.08 | 0.25 | 0.34 | 0.46 | 0.42 | 0.53 | 0.85 | 0.76 | 0.80 | 0.67 |
| Debt / EBITDA | - | - | - | - | - | - | - | - | - | - |
| Interest coverage | -8.3x | -8.1x | -7.2x | - | -4.8x | -3.1x | -3.7x | - | -4.4x | -3.9x |
| Equity multiplier | 23.05 | 27.11 | 28.05 | 28.78 | 7.15 | 21.54 | -3.78 | -6.68 | -8.13 | -17.06 |
| Liabilities / Assets | 0.95 | 0.96 | 0.96 | 0.96 | 0.85 | 0.95 | 1.26 | 1.14 | 1.12 | 1.05 |
| Efficiency | ||||||||||
| Asset turnover | 0.22 | 0.25 | 0.21 | - | 0.21 | 0.21 | 0.21 | - | 0.18 | 0.19 |
| Inventory turnover | 0.31 | 0.39 | 0.28 | - | 0.27 | 0.24 | 0.28 | - | 0.23 | 0.26 |
| Days sales outstanding | 437d | 367d | 449d | - | 513d | 541d | 567d | - | 708d | 682d |
| Days inventory outstanding | 1161d | 925d | 1317d | - | 1357d | 1526d | 1313d | - | 1572d | 1430d |
| Days payable outstanding | 523d | 341d | 550d | - | 511d | 554d | 487d | - | 479d | 517d |
| Cash conversion cycle | 1075d | 950d | 1215d | - | 1359d | 1512d | 1393d | - | 1802d | 1595d |
| Valuation | ||||||||||
| P / E | - | - | - | - | - | - | - | - | - | - |
| P / B | 1.6x | 1.5x | 0.9x | - | 4.8x | 15.2x | - | - | - | - |
| P / S | 0.3x | 0.2x | 0.1x | - | 3.2x | 3.4x | 2.5x | - | 6.8x | 6.3x |
| EV / EBITDA | - | - | - | - | - | - | - | - | - | - |
| Growth | ||||||||||
| Revenue growth (YoY) | -8.2% | -5.4% | -21.9% | - | -14.8% | -17.4% | -14.9% | - | -18.2% | -26.4% |
| Revenue CAGR (3y) | -13.8% | -16.8% | -19.8% | - | -15.1% | -13.7% | -8.2% | - | -5.2% | 5.7% |
| Revenue CAGR (5y) | -7.8% | -1.6% | -1.2% | - | 35.3% | 24.8% | 26.5% | - | 29.6% | 29.7% |
| Gross profit growth (YoY) | -11.1% | -20.4% | -24.8% | - | -18.6% | -16.7% | -15.0% | - | -8.9% | -25.3% |
| Operating income growth (YoY) | -32.7% | -61.6% | -22.8% | - | -5.8% | 2.8% | 4.8% | - | 40.8% | 19.2% |
| Net income growth (YoY) | -143.0% | 41.3% | -26.2% | - | 36.4% | -169.3% | -1.4% | - | 0.0% | 29.8% |
| EPS growth (YoY) | 13.8% | 76.1% | 5.6% | - | 22.0% | -125.9% | -898.9% | - | -8100.0% | -9181.3% |
| EPS CAGR (3y) | - | - | - | - | - | - | - | - | - | - |
| EPS CAGR (5y) | - | - | - | - | - | - | - | - | - | - |
| FCF growth (YoY) | - | - | -118.6% | - | - | - | 51.3% | - | - | - |
| FCF CAGR (5y) | - | - | - | - | - | - | - | - | - | - |
| Book value growth (YoY) | -73.6% | -37.1% | - | - | - | - | -2438.0% | - | - | - |
Sales by segment
From XBRL dimensional facts in the 10-K period ending 2024-12-31.
Product / service
$64.83M totalSystem$38.02M · 58.6%
Leases$13.27M · 20.5%
Product$10.47M · 16.1%
Service$3.08M · 4.7%
Geographic
$64.83M totalUS$38.18M · 58.9%
Non Us$26.66M · 41.1%
Peer comparison
Same SIC group: Surgical & Medical Instruments & Apparatus
Comparing Venus Concept Inc. against the 5 most active filers in the same SIC group.